Global Inflammatory Bowel Disease (IBD) Market 2021-2026 Featuring Johnson & Johnson, AbbVie, Takeda, Pfizer, Roche, Celgene, GlaxoSmithKline, Novartis, UCB and Eli Lilly & Co

Source :: PR Newswire. December 15, 2021
Publication Year :: 2021
Abstract: DUBLIN, Dec. 15, 2021 /PRNewswire/ -- The 'Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel, By Region, By Country [...]

Subjects :: Johnson & Johnson -- Forecasts and trends
AbbVie Inc. -- Forecasts and trends
Pfizer Inc. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Eli Lilly and Co. -- Forecasts and trends
Celgene Corp. -- Forecasts and trends
Distribution channels -- Forecasts and trends
Medical research -- Forecasts and trends
Medicine, Experimental -- Forecasts and trends
Ulcerative colitis -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Direct market channel
Retail/reseller channel
Market trend/market analysis
Business
News, opinion and commentary

Tools